Fig. 1: Phenotypic characterization of hPB MNCs and CD34+ cells
Marked recruitment of CD34+ cells, not MNCs, labeled with Qtracker were observed around fracture site by fluorescence microscopy at day 7 (Fig. 2) .
Fig. 2: Recruitment of Qtracker-labeled CD34+ cells
Immunohistochemical staining (a) and RT-PCR (b) at the perifracture site demonstrated expression of human specific markers for ECs and OBs 14 days after CD34+ cell transplantation (Fig. 3) .
Fig. 3: Human CD34+ cell-derived vasculogenesis and osteogenesis
Necropsy examination at day 14 disclosed augumentation of capillary density and osteoblast density (Fig. 4) .
Fig. 4: Enhanced intrinsic vascularization and osteogenesis by recipient's cells following CD34+ cell transplantation
Fractures were completely healed with the bridging callus assessed by radiological and histological examinations at week 8 after CD34+ cell transplantation, while all fractures in other groups fell into nonunions. Three point bending test at week 8 revealed significantly functional healing by CD34+ cell transplantation compared to controls (Fig. 5) . fracture healing following CD34+ cell transplantation Discussion Our findings indicate that CD34+ cell fraction contains not only endothelial progenitor cells but also a few number of multipotent stem and/or committed osteogenic progenitor cells, subsequently representing the osteogenic activity under the microenvironment of fracture. This mechanism may, at least in part, contribute to enhanced functional recovery of bone healing following CD34+ cell transplantation. In conclusion, our data suggest therapeutic potential of circulating human CD34+ cells in promoting an environment conductive to neovascularization and osteogenesis in damaged skeletal tissue so that fractures can completely heal. 
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